Review article: evidence‐based dietary advice for patients with inflammatory bowel disease
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Summary: Background: The therapeutic effect of enteral nutrition in Crohn's disease (CD) and the epidemiological associations between diet and inflammatory bowel disease (IBD) implicate diet in IBD causation. There is little evidence, however, to support specific dietary changes and patients often receive contradictory advice. Aim: To review the literature on the impacts of diet on IBD causation and activity to produce guidance based on ‘best available evidence’. Method: Review of Medline, Embase and Cochrane databases from 1975 to 2012 using Me SH headings ‘crohn's disease’ ‘ulcerative colitis’ ‘enteral’ ‘diet’ ‘nutrition’ ‘fatty acid’ and ‘food additives’. Results: Enteral nutrition with a formula‐defined feed is effective treatment for CD, but approximately 50% of patients relapse within 6 months of return to normal diet. There is no direct evidence of benefit from any other specific dietary modification in CD, but indirect evidence supports recommendation of a low intake of animal fat, insoluble fibre and processed fatty foods containing emulsifiers. Foods tolerated in sustained remission may not be tolerated following relapse. Some evidence supports vitamin D supplementation. In ulcerative colitis (UC), evidence is weaker, but high intakes of meat and margarine correlate with increased UC incidence and high meat intake also correlates with increased likelihood of relapse. Conclusions: There is little evidence from interventional studies to support specific dietary recommendations. Nevertheless, people with IBD deserve advice based on ‘best available evidence’ rather than no advice at all, although dietary intake should not be inappropriately restrictive. Further interventional studies of dietary manipulation are urgently required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Diet Drives Convergence in Gut Microbiome Functions Across Mammalian Phylogeny and Within Humans
Muegge, B. D., Kuczynski, J., Knights, D., Clemente, J. C., González, A., Fontana, L., Henrissat, B., Knight, R., & Gordon, J. I. (2011) · Science · doi:10.1126/science.1198719 · Cited by 1,988 · cited 1×
“Such correlations between diet and microbiota also exist across mammalian species.(83)”
BackgroundDietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice
Devkota, S., Wang, Y., Musch, M. W., Leone, V., Fehlner-Peach, H., Nadimpalli, A., Antonopoulos, D. A., Jabri, B., & Chang, E. B. (2012) · Nature · doi:10.1038/nature11225 · Cited by 1,904
Bolland, M. J., Avenell, A., Baron, J. A., Grey, A., MacLennan, G. S., Gamble, G. D., & Reid, I. R. (2010) · BMJ · doi:10.1136/bmj.c3691 · Cited by 1,099 · cited 1×
“59) and smaller, nonsignificant, increases in the risk of stroke and mortality.(47)”
BackgroundHou, J. K., Abraham, B., & El-Serag, H. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.44 · Cited by 1,009 · cited 15×
“Sugar and fibre: Intervention studies do not support avoidance of sugar or increased intake of fibre (nonstarch polysaccharide) in CD.”
BackgroundInfluentialLindsay, J. O. (2006) · Gut · doi:10.1136/gut.2005.074971 · Cited by 471
Jowett, S. L., Seal, C. J., Pearce, M. S., Phillips, E., Gregory, W., Barton, J. R., & Welfare, M. R. (2004) · Gut · doi:10.1136/gut.2003.024828 · Cited by 462
Benjamin, J. L., Hedin, C. R. H., Koutsoumpas, A., Ng, S. C., McCarthy, N. E., Hart, A. L., Kamm, M. A., Sanderson, J. D., Knight, S. C., Forbes, A., et al. (2011) · Gut · doi:10.1136/gut.2010.232025 · Cited by 361 · cited 1×
“A pilot study in CD suggested that FOS may be of benefit(53); however, a subsequent randomised controlled trial showed no benefit and even some worsening of symptoms.(54)”
BackgroundTAKAGI, S., UTSUNOMIYA, K., KURIYAMA, S., YOKOYAMA, H., TAKAHASHI, S., IWABUCHI, M., TAKAHASHI, H., TAKAHASHI, S., KINOUCHI, Y., HIWATASHI, N., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03120.x · Cited by 292
Categorization of the gut microbiota: enterotypes or gradients?
Jeffery, I. B., Claesson, M. J., O'Toole, P. W., & Shanahan, F. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2859 · Cited by 238 · cited 1×
“that the distinctions between enterotypes are not sharp, but graded.(80) In healthy individuals, different long-term diets correlate with different enterotypes – thus a predominant Bacteroides enterotype is associated with a”
Background
Cited by
ESPEN guideline: Clinical nutrition in inflammatory bowel disease
Forbes, A., Escher, J., Hébuterne, X., Kłęk, S., Krznaric, Z., Schneider, S., Shamir, R., Stardelova, K., Wierdsma, N., Wiskin, A. E., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.12.027 · Cited by 625
RetractedESPEN guideline on Clinical Nutrition in inflammatory bowel disease
Bischoff, S. C., Bager, P., Escher, J., Forbes, A., Hébuterne, X., Hvas, C. L., Joly, F., Klek, S., Krznaric, Z., Ockenga, J., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2022.12.004 · Cited by 367
ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease
Bischoff, S. C., Escher, J., Hébuterne, X., Kłęk, S., Krznaric, Z., Schneider, S., Shamir, R., Stardelova, K., Wierdsma, N., Wiskin, A. E., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.11.002 · Cited by 351
Diet and inflammatory bowel disease: the Asian Working Group guidelines
Sood, A., Ahuja, V., Kedia, S., Midha, V., Mahajan, R., Mehta, V., Sudhakar, R., Singh, A., Kumar, A., Puri, A. S., et al. (2019) · Indian Journal of Gastroenterology · doi:10.1007/s12664-019-00976-1 · Cited by 54
Li, D., Zhou, J., Wang, L., Gong, Z., Le, H., Huang, Y., Xu, C., Tian, C., Cai, W., & Wu, J. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01109-0 · Cited by 35
Dietary beliefs and behaviors among parents of children with inflammatory bowel disease
Pituch-Zdanowska, A., Kowalska-Duplaga, K., Jarocka-Cyrta, E., Stawicka, A., Dziekiewicz, M., & Banaszkiewicz, A. (2019) · Journal of Medicinal Food · doi:10.1089/jmf.2018.0206 · Cited by 23
Chuong, K. H., Haw, J., Stintzi, A., Mack, D. R., & O’Doherty, K. C. (2019) · International Journal of Qualitative Studies on Health and Well-Being · doi:10.1080/17482631.2019.1648945 · Cited by 21
“According to a review by Richmond and Rhodes (2013), EEN is effective for CD although many patients relapse within 6 months after their return to a normal diet.”
Method
Metadata
- Authors
- Richman, E., & Rhodes, J. M.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2013-09-17
- Volume
- 38
- Issue
- 10
- Pages
- 1156-1171
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W1996646312
- Cited by
- 114
- References
- 15
- FWCI
- 6.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.